Carbogen Amcis

CARBOGEN AMCIS is a leading global Contract Development and Manufacturing Organization (CDMO) providing comprehensive drug development and commercialization services. The company specializes in the process development and manufacturing of Active Pharmaceutical Ingredients (APIs) and complex drug products, with a particular focus on highly potent APIs (HPAPIs) and Antibody-Drug Conjugates (ADCs). As a subsidiary of the Dishman Carbogen Amcis Group, the company operates eight state-of-the-art facilities across Switzerland, France, the United Kingdom, the Netherlands, and China. Their services span the entire drug lifecycle, from preclinical discovery support and clinical trial material production to large-scale commercial manufacturing and sterile fill-finish services.